Re-evaluation of in vivo selectivity of [11C]SA4503 to σ1 receptors in the brain: Contributions of emopamil binding protein

Nuclear Medicine and Biology

Volumn 39, Issue 7, 2012, Pages 1049-1052

  Toyohara, Jun ^a   Sakata, Muneyuki ^a   Ishiwata, Kiichi ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

1 receptor; 11C SA4503; Emopamil binding protein

Indexed keywords

1 [2 (3,4 DIMETHOXYPHENYL)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE C 11; BINDING PROTEIN; CUTAMESINE; EMOPAMIL BINDING PROTEIN; HALOPERIDOL; IFENPRODIL; RADIOLIGAND; SIGMA 1 OPIATE RECEPTOR; TAMOXIFEN; TRIFLUOPERAZINE; TRIFLUPERIDOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN; DOSE RESPONSE; DRUG SELECTIVITY; DRUG UPTAKE; IN VIVO STUDY; MOUSE; NONHUMAN; RADIOACTIVITY;

ANIMALS; BIOLOGICAL TRANSPORT; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HUMANS; MICE; PIPERAZINES; RATS; RECEPTORS, SIGMA; STEROID ISOMERASES; SUBSTRATE SPECIFICITY;

EID: 84866013619     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2012.03.002     Document Type: Article

References (34)

1. Ishikawa M., Hashimoto K. The role of sigma-1 receptors in the pathophysiology of neuropsychiatric diseases. J Recept Ligand Channel Res 2010, 3:25-36.
2. 2+ signaling and cell survival. Cell 2007, 131:596-610.
3. 3H-acetylcholine from striatal and hippocampal rat brain slices. Synapse 2002, 46:1-3.
4. Kobayashi T., Matsuno K., Nakata K., Mita S. Enhancement of acetylcholine release by SA4503, a novel sigma 1 receptor agonist, in the brain. J Pharmacol Exp Ther 1996, 279:106-113.
5. 1-like receptors. J Biol Chem 2002, 277:28725-28732.
6. 1-binding site. Proc Natl Acad Sci USA 1996, 93:8072-8077.
7. Moebius F.F., Striessnig J., Glossmann H. The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. Trends Pharmacol Sci 1997, 18:67-70.
8. Su T.P., London E.D., Jaffe J.H. Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science 1988, 240:219-221.
9. 2+ antagonist binding protein. J Biol Chem 1995, 270:7551-7557.
10. Silve S., Dupuy P.H., Labit-Lebouteiller C., Kaghad M., Chalon P., Rahier A., et al. Emopamil-binding protein, a mammalian protein that binds a series of structurally diverse neuroprotective agents, exhibits δ8-δ7 sterol isomerase activity in yeast. J Biol Chem 1996, 271:22434-22440.
11. 1 and EBP sites. Bioorg Med Chem 2001, 9:1325-1335.
12. 1-binding sites for sterol isomerization inhibitors: evidence for a pharmacological relationship with the yeast sterol δ8-δ7 isomerase. Br J Phatmacol 1997, 121:1-6.
13. 3H]ifenprodil. Mol Pharmacol 1998, 54:591-598.
14. 2-like receptors. Ann Nucl Med 2006, 20:569-573.
15. 11C]SA4503. Biol Psychiatry 2007, 62:878-883.
16. 11C]SA4503. Int J Neuropsychopharmacol 2009, 12:1127-1131.
17. 1 receptors in early Alzheimer's disease. Ann Nucl Med 2008, 22:151-156.
18. 1 receptors in Parkinson's disease. Acta Neurol Scand 2005, 112:103-107.
19. 1 receptor agonist. Eur J Pharmacol 1996, 306:271-279.
20. 2 receptor binding affinity and selectivity of SA4503 and fluoroethyl SA4503. Synapse 2006, 59:350-358.
21. Shiba K., Ogawa K., Ishiwata K., Yajima K., Mori H. Synthesis and binding affinities of methylvesamicol analogs for the acetylcholine transporter and sigma receptor. Bioorg Med Chem 2006, 14:2820-2826.
22. 11C]SA4503. Nucl Med Biol 2006, 33:543-548.
23. Hirata M., Mori T., Soga S., Umeda T., Ohmomo Y. Synthesis and in vitro evaluation of iodinated derivatives of piperazine as a new ligand for sigma receptor imaging by single photon emission computed tomography. Chem Pharm Bull 2006, 54:470-475.
24. 50) of an enzymatic reaction. Biochem Pharmacol 1973, 22:3099-3108.
25. Fujimura K., Matsumoto J., Niwa M., Kobayashi T., Kawashima Y., In Y., et al. Synthesis, structure and quantitative structure-activity relationships of σ receptor ligands, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazines. Bioorg Med Chem 1997, 5:1675-1683.
26. 11C]methyl triflate. Ann Nucl Med 2004, 18:165-168.
27. 1 receptors in the cat brain. Ann Nucl Med 2000, 14:285-292.
28. 18F]fluspidine. Eur J Nucl Med Mol Imaging 2011, 38:540-551.
29. 1 receptor at endoplasmic reticulum and nuclear envelope level. Eur J Biochem 1999, 263:377-386.
30. Katzenellenbogen J.A., Heiman D.F., Carlson K.E., Lloyd J.E. In vitro and in vivo steroid receptor assays in the design of estrogen radiopharmaceuticals. Receptor Binding Radiotracers 1982, Vol. 1:93-126. CRC Press, Boca Raton, FL. W.C. Eckelman (Ed.).
31. Eckelman W.C. Radiolabeled adrenergic and muscarinic blockers for in vivo studies. Receptor Binding Radiotracers 1982, Vol. 1:69-92. CRC Press, Boca Raton, FL. W.C. Eckelman (Ed.).
32. Eckelman W.C. The application of receptor theory to receptor-binding and enzyme-binding oncologic radiopharmaceuticals. Nucl Med Biol 1994, 21:759-769.
33. 1 receptors. Nucl Med Biol 2000, 27:255-261.
34. 11C]SA4503. Neuroimage 2007, 35:1-8.